Implant to Fight Addition

The U.S. Food and Drug Administration approved the first-ever implant to fight opioid addiction. Titan Pharmaceuticals Inc. and Braeburn Pharmaceuticals developed the matchstick-stick implant administers buprenorphine for up to six months. Read article here…..

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.